Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ganesh V Raj

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Oncology (Williston Park, N.Y.)|October 18, 2014
An Extended Time Frame for VTE Risk in Bladder CancerGanesh V Raj, Farshid Araghizadeh
Frontiers in Oncology|June 2, 2012
Management of biochemical recurrence after primary localized therapy for prostate cancerOussama M Darwish, Ganesh V Raj
Urology|August 4, 2009
Growing teratoma syndromeJose A Karam, Ganesh V Raj
International Journal of Surgical Oncology|February 8, 2012
Lymphadenectomy in management of invasive bladder cancerRamy F Youssef, Ganesh V Raj
Nature Reviews. Urology|November 23, 2016
Surgery: The surgeon-scientist - a dying breed?Solomon L Woldu, Ganesh V Raj
Seminars in Oncology|March 27, 2007
Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standardGanesh V Raj, Bernard H Bochner
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Molecular mechanisms of enzalutamide resistance in prostate cancerEliot B Blatt, Ganesh V Raj
Expert Opinion on Emerging Drugs|September 5, 2022
Emerging hormonal agents for the treatment of prostate cancerEmily Bochner, Sam Gold, Ganesh V Raj
Expert Opinion on Pharmacotherapy|September 6, 2019
An evaluation of fulvestrant for the treatment of metastatic breast cancerMohsin Soleja, Ganesh V Raj, Nisha Unni
Expert Review of Clinical Pharmacology|February 15, 2018
A new class of agents for estrogen-receptor-positive breast cancerDede N Ekoue, Nisha Unni, Ganesh V Raj
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Oncology (Williston Park, N.Y.)|October 18, 2014
An Extended Time Frame for VTE Risk in Bladder CancerGanesh V Raj, Farshid Araghizadeh
Frontiers in Oncology|June 2, 2012
Management of biochemical recurrence after primary localized therapy for prostate cancerOussama M Darwish, Ganesh V Raj
Urology|August 4, 2009
Growing teratoma syndromeJose A Karam, Ganesh V Raj
International Journal of Surgical Oncology|February 8, 2012
Lymphadenectomy in management of invasive bladder cancerRamy F Youssef, Ganesh V Raj
Nature Reviews. Urology|November 23, 2016
Surgery: The surgeon-scientist - a dying breed?Solomon L Woldu, Ganesh V Raj
Seminars in Oncology|March 27, 2007
Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standardGanesh V Raj, Bernard H Bochner
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Molecular mechanisms of enzalutamide resistance in prostate cancerEliot B Blatt, Ganesh V Raj
Expert Opinion on Emerging Drugs|September 5, 2022
Emerging hormonal agents for the treatment of prostate cancerEmily Bochner, Sam Gold, Ganesh V Raj
Expert Opinion on Pharmacotherapy|September 6, 2019
An evaluation of fulvestrant for the treatment of metastatic breast cancerMohsin Soleja, Ganesh V Raj, Nisha Unni
Expert Review of Clinical Pharmacology|February 15, 2018
A new class of agents for estrogen-receptor-positive breast cancerDede N Ekoue, Nisha Unni, Ganesh V Raj
Pageof 17